CKD Bio Corp. (KRX: 063160)
South Korea flag South Korea · Delayed Price · Currency is KRW
22,600
-350 (-1.53%)
Dec 19, 2024, 3:30 PM KST

CKD Bio Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 2017 - 2013
Period Ending
Sep '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 2017 - 2013
Operating Revenue
159,935156,042142,238124,600137,184124,510
Upgrade
Other Revenue
-0-0--00
Upgrade
Revenue
159,935156,042142,238124,600137,184124,510
Upgrade
Revenue Growth (YoY)
3.59%9.70%14.16%-9.17%10.18%9.45%
Upgrade
Cost of Revenue
152,985139,252128,93296,736101,010101,090
Upgrade
Gross Profit
6,95016,79013,30627,86436,17423,420
Upgrade
Selling, General & Admin
15,05715,51312,58510,66410,0578,530
Upgrade
Research & Development
16,27715,43211,5169,11810,7047,881
Upgrade
Operating Expenses
32,00731,60024,73820,25720,76116,411
Upgrade
Operating Income
-25,058-14,810-11,4327,60715,4137,009
Upgrade
Interest Expense
-4,564-2,938-1,936-627.81-153.41-129.16
Upgrade
Interest & Investment Income
334.5248.066.7921.03111.69223.47
Upgrade
Currency Exchange Gain (Loss)
286.01-358.41,650-1,214777.11942.59
Upgrade
Other Non Operating Income (Expenses)
2,804-542.18-1,6881,273-487.09379.89
Upgrade
EBT Excluding Unusual Items
-26,198-18,601-13,3997,05915,6618,426
Upgrade
Gain (Loss) on Sale of Investments
-776.650.18-0.97-1.5919.15-148.26
Upgrade
Gain (Loss) on Sale of Assets
180.7311.1542.641.54-41.7195.81
Upgrade
Pretax Income
-26,794-18,590-13,3587,05915,6389,295
Upgrade
Income Tax Expense
-3,664-1,887-6,781851.983,3731,339
Upgrade
Net Income
-23,130-16,703-6,5776,20712,2657,956
Upgrade
Net Income to Common
-23,130-16,703-6,5776,20712,2657,956
Upgrade
Net Income Growth
----49.39%54.16%12.04%
Upgrade
Shares Outstanding (Basic)
555555
Upgrade
Shares Outstanding (Diluted)
555555
Upgrade
Shares Change (YoY)
-0.02%-1.40%0.45%-0.00%-0.03%
Upgrade
EPS (Basic)
-4216.38-3044.61-1198.811147.302277.201477.21
Upgrade
EPS (Diluted)
-4216.38-3044.61-1198.811147.302277.201477.21
Upgrade
EPS Growth
----49.62%54.16%12.07%
Upgrade
Free Cash Flow
-22,830-9,404-26,368-56,835-30,324-860.71
Upgrade
Free Cash Flow Per Share
-4161.70-1714.22-4806.49-10504.67-5630.22-159.81
Upgrade
Dividend Per Share
--100.000200.000190.476190.476
Upgrade
Dividend Growth
---50.00%5.00%0%-
Upgrade
Gross Margin
4.35%10.76%9.35%22.36%26.37%18.81%
Upgrade
Operating Margin
-15.67%-9.49%-8.04%6.11%11.23%5.63%
Upgrade
Profit Margin
-14.46%-10.70%-4.62%4.98%8.94%6.39%
Upgrade
Free Cash Flow Margin
-14.27%-6.03%-18.54%-45.61%-22.10%-0.69%
Upgrade
EBITDA
-7,3973,1285,55219,84225,18915,965
Upgrade
EBITDA Margin
-4.63%2.00%3.90%15.92%18.36%12.82%
Upgrade
D&A For EBITDA
17,66117,93816,98412,2359,7778,956
Upgrade
EBIT
-25,058-14,810-11,4327,60715,4137,009
Upgrade
EBIT Margin
-15.67%-9.49%-8.04%6.11%11.23%5.63%
Upgrade
Effective Tax Rate
---12.07%21.57%14.40%
Upgrade
Advertising Expenses
-163.7242.4812.66239.71249.69
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.